Christine Mannhalter | Academic Influence

Christine Mannhalter's AcademicInfluence.com Rankings

Christine Mannhalter

Medical

#2403

World Rank

#2826

Historical Rank

Hematology

#52

World Rank

#58

Historical Rank

medical Degrees

Christine Mannhalter

Biology

#5788

World Rank

#8355

Historical Rank

Molecular Biology

#1281

World Rank

#1308

Historical Rank

biology Degrees

Download Badge

Medical
Biology

Christine Mannhalter's Degrees

Doctorate Medicine Medical University of Vienna
PhD Molecular Biology Medical University of Vienna

Why Is Christine Mannhalter Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Christine Mannhalter is an Austrian molecular biologist and hematologist who is a Professor of Molecular Diagnostics at the Medical University of Vienna. She has been a vice-president at the Austrian Science Fund since 2010 and took over its interim presidency in 2015.

(See a Problem?)

Christine Mannhalter's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease (2002) (550)
Is Elevated Mean Platelet Volume Associated With a Worse Outcome in Patients With Acute Ischemic Cerebrovascular Events? (2004) (342)
The Risk of Recurrent Venous Thromboembolism in Patients with and without Factor V Leiden (1997) (219)
Risk of pregnancy‐associated recurrent venous thromboembolism in women with a history of venous thrombosis (2005) (217)
Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets (2017) (211)
Most CD56+ intestinal lymphomas are CD8+CD5-T-cell lymphomas of monomorphic small to medium size histology. (1998) (204)
Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. (2002) (196)
Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial. (2014) (194)
Primary follicular lymphoma of the duodenum is a distinct mucosal/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. (2011) (182)
Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy (2004) (173)
Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia. (2014) (172)
Heme Oxygenase-1 Gene Promoter Microsatellite Polymorphism is Associated with Restenosis after Percutaneous Transluminal Angioplasty (2001) (172)
A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. (1998) (172)
Clinical studies and thrombin generation in patients homozygous or heterozygous for the G20210A mutation in the prothrombin gene. (1998) (171)
Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression. (1995) (170)
Protein S Deficiency: A Database of Mutations – Summary of the First Update (2000) (162)
Follicular lymphomas' BCL-2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation. (2000) (158)
The Risk of Early Recurrent Venous Thromboembolism after Oral Anticoagulant Therapy in Patients with the G20210A Transition in the Prothrombin Gene (1999) (146)
High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia (2005) (146)
Factor V Leiden and Prothrombin Gene G 20210 A Variant in Children with Ischemic Stroke (1998) (143)
Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients. (1997) (132)
High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant. (2007) (124)
The Prevalence of Factor XII Deficiency in 103 Orally Anticoagulated Outpatients Suffering from Recurrent Venous and/or Arterial Thromboembolism (1992) (121)
Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia (1997) (120)
Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma. (2001) (120)
Prospective Evaluation of Hemostatic System Activation and Thrombin Potential in Healthy Pregnant Women with and without Factor V Leiden (1999) (118)
Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. (2003) (115)
Thrombin as a multi-functional enzyme (2011) (112)
Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene (2005) (112)
Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia. (1997) (111)
Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm. (2002) (109)
Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. (1994) (107)
Evidence of a U‐shaped association between factor XII activity and overall survival (2007) (107)
Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. (2004) (101)
Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response (2012) (99)
The Prevalence of Moderate and Severe FXII (Hageman Factor) Deficiency among the Normal Population: Evaluation of the Incidence of FXII Deficiency among 300 Healthy Blood Donors (1994) (97)
Association of a Functional Polymorphism in the Clopidogrel Target Receptor Gene, P2Y12, and the Risk for Ischemic Cerebrovascular Events in Patients With Peripheral Artery Disease (2005) (94)
Matched Case-Control Study on Factor V Leiden and the Prothrombin G20210A Mutation in Patients With Ischemic Stroke/Transient Ischemic Attack Up to the Age of 60 Years (2005) (93)
High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia (2004) (91)
Protein S Deficiency: A Database of Mutations (1997) (90)
Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16). (2002) (90)
Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia (2002) (86)
Evaluation of RNA Isolation Methods and Reference Genes for RT-PCR Analyses of Rare Target RNA (2000) (86)
The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism. (2002) (83)
Major determinants of hyperhomocysteinemia in peritoneal dialysis patients. (1998) (82)
Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy. (2006) (82)
A Meta-Analysis of Candidate Gene Polymorphisms and Ischemic Stroke in 6 Study Populations: Association of Lymphotoxin-Alpha in Nonhypertensive Patients (2009) (82)
Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study. (1997) (80)
Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia (1998) (80)
The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease (2014) (80)
A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease (2003) (80)
Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication ofHelicobacter pylori (2000) (79)
Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes. (2002) (78)
The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events. (2003) (76)
Immunoreactivity of B-Cell Markers (CD79a, L26) in Rare Cases of Extranodal Cytotoxic Peripheral T- (NK/T-) Cell Lymphomas (2000) (75)
Molecular Cytogenetic Evidence of t(14;18)(IGH;BCL2) in a Substantial Proportion of Primary Cutaneous Follicle Center Lymphomas (2006) (74)
ABO mismatch increases transplant‐related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation (2003) (74)
4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia (2005) (73)
Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events (2006) (73)
Donor heme oxygenase-1 genotype is associated with renal allograft function1 (2004) (72)
Preeclampsia and Fetal Loss in Women With a History of Venous Thromboembolism (2001) (72)
Influence of functional haplotypes in the drug transporter gene ABCB1 on central nervous system drug distribution in humans (2005) (72)
ORAL CONTRACEPTIVES ENHANCE THE RISK OF CLINICAL MANIFESTATION OF VENOUS THROMBOSIS AT A YOUNG AGE IN FEMALES HOMOZYGOUS FOR FACTOR V LEIDEN (1996) (70)
Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden. (2000) (70)
Factor XII activity and antigen concentrations in patients suffering from recurrent thrombosis (1987) (68)
Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas. (2014) (66)
The interleukin-6 G(-174)C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans. (2004) (65)
Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk (2008) (65)
Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients – results from the Vienna Cancer And Thrombosis Study (CATS) (2015) (63)
C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: a case-control study. (1999) (62)
The 4G/4G genotype at nucleotide position −675 in the promotor region of the plasminogen activator inhibitor 1 (PAI‐1) gene is less frequent in young patients with minor stroke than in controls (2000) (61)
A microsatellite polymorphism in the heme oxygenase‐1 gene promoter is associated with risk for melanoma (2006) (60)
Quantification of minimal residual disease in patients with BCR‐ABL‐positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction (1999) (60)
FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia (1996) (60)
Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation. (2000) (60)
Low‐density lipoprotein receptor‐related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolism (2007) (58)
Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome (2005) (57)
Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease? (2003) (57)
Genetic fingerprinting in mouthwashes of patients after allogeneic bone marrow transplantation (1999) (57)
Protein S deficiency type I: identification of point mutations in 9 of 10 families. (1995) (56)
GAB2 is a novel target of 11q amplification in AML/MDS (2006) (55)
Routinely available biomarkers improve prediction of long-term mortality in stable coronary artery disease: the Vienna and Ludwigshafen Coronary Artery Disease (VILCAD) risk score. (2012) (54)
Human high molecular weight kininogen. Effects of cleavage by kallikrein on protein structure and procoagulant activity. (1980) (54)
Haem oxygenase‐1 genotype and cardiovascular adverse events in patients with peripheral artery disease (2005) (52)
Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia (2016) (52)
CD5 Expression in a Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT)-Type as a Marker for Early Dissemination and Aggressive Clinical Behaviour (2001) (52)
Parameters influencing FVIII pharmacokinetics in patients with severe and moderate haemophilia A (2015) (51)
A rapid method for the isolation of genomic DNA from citrated whole blood. (1991) (51)
Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge (2002) (50)
High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V (2010) (49)
Mechanism of the chromosomal translocation t(14;18) in lymphoma: detection of a 45-Kd breakpoint binding protein. (1993) (49)
Defective diacylglycerol‐induced Ca2+entry but normal agonist‐induced activation responses in TRPC6‐deficient mouse platelets (2012) (49)
A common C-->T polymorphism at nt 46 in the promoter region of coagulation factor XII is associated with decreased factor XII activity. (2001) (48)
Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML (2015) (48)
4G4G genotype of the plasminogen activator inhibitor‐1 promoter polymorphism associates with disseminated intravascular coagulation in children with systemic meningococcemia (2007) (48)
The effect of a promoter polymorphism in the heme oxygenase-1 gene on the risk of ischaemic cerebrovascular events: the influence of other vascular risk factors. (2004) (48)
Homocysteine levels in polycythaemia vera and essential thrombocythaemia (1999) (47)
Multiplex PCR for rapid detection of T‐cell receptor‐gamma chain gene rearrangements in patients with lymphoproliferative diseases (1996) (47)
Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome (2004) (47)
Homozygosity for the C→T polymorphism at nucleotide 46 in the 5′ untranslated region of the factor XII gene protects from development of acute coronary syndrome (2001) (46)
Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine. (2008) (45)
Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (Humara). Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosis. (1999) (44)
Heme Oxygenase-1 Genotype is a Vascular Anti-inflammatory Factor following Balloon Angioplasty (2002) (44)
Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines. (2007) (44)
Overexpression of uridine diphospho glucuronosyltransferase 2B17 in high-risk chronic lymphocytic leukemia. (2013) (44)
PCR‐monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR‐ABL‐positive acute lymphoblastic leukaemia (1995) (44)
Is low serum bilirubin an independent risk factor for coronary artery disease in men but not in women? (2003) (44)
Monitoring of minimal residual leukemia in patients with MLL-AF9 positive acute myeloid leukemia by RT-PCR (1999) (44)
RAPID ESTABLISHMENT OF LONG‐TERM CULTURE‐INITIATING CELLS OF DONOR ORIGIN AFTER NONMYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM‐CELL TRANSPLANTATION, AND SIGNIFICANT PROGNOSTIC IMPACT OF DONOR T‐CELL CHIMERISM ON STABLE ENGRAFTMENT AND PROGRESSION‐FREE SURVIVAL (2003) (44)
Identification of oncostatin M as a JAK2 V617F‐dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms (2012) (43)
Transcription of AML1/ETO in bone marrow and cord blood of individuals without acute myelogenous leukemia. (2002) (43)
Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia (2003) (42)
Genetic and nongenetic factors influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and in healthy control subjects. (1999) (42)
The K121Q polymorphism in the plasma cell membrane glycoprotein 1 gene predisposes to early myocardial infarction (2002) (40)
Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A (2004) (40)
Post-transplant acute myeloid leukemia (PT-AML) (1999) (39)
PML‐RARα PCR positivity in the bone marrow of patients with APL precedes haematological relapse by 2–3 months (1994) (39)
Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia (2014) (39)
Common IgE-epitopes of recombinant Phl p I, the major timothy grass pollen allergen and natural group I grass pollen isoallergens. (1996) (38)
Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis. (1995) (38)
Platelet‐borne complement proteins and their role in platelet–bacteria interactions (2016) (38)
The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanoma. (2006) (37)
Monitoring of minimal residual disease in patients with MLL–AF6‐positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction (2000) (37)
The biological and clinical significance of MLL abnormalities in haematological malignancies (2004) (37)
High Levels of Plasma Protein C in Nephrotic Syndrome (1985) (37)
Thrombophilic polymorphisms – factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations – and preterm birth (2004) (36)
Candidate genetic risk factors of stroke: results of a multilocus genotyping assay. (2007) (36)
Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women (2010) (36)
Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL) (2004) (35)
Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis (2018) (35)
Twelve novel and two recurrent mutations in 14 Austrian families with hereditary protein C deficiency (1993) (35)
High proportion of patients with bleeding of unknown cause in persons with a mild‐to‐moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB) (2018) (35)
Activation of endothelium by immunotherapy with interleukin‐2 in patients with malignant disorders (1999) (34)
Polymorphisms in the interleukin-1 gene cluster in children and young adults with systemic meningococcemia. (2006) (34)
Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors (1998) (33)
P-selectin gene haplotypes modulate soluble P-selectin concentrations and contribute to the risk of venous thromboembolism (2008) (33)
Relative seroprevalence of human herpes viruses in patients with chronic lymphocytic leukaemia (2009) (33)
Differential impact of cytochrome 2C9 allelic variants on clopidogrel-mediated platelet inhibition determined by five different platelet function tests. (2013) (33)
Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort study. (2005) (33)
Combined polymerase chain reaction approach for clonality detection in lymphoid neoplasms. (1999) (33)
Multiplexed mutagenically separated PCR: simultaneous single-tube detection of the factor V R506Q (G1691A), the prothrombin G20210A, and the methylenetetrahydrofolate reductase A223V (C677T) variants. (2001) (33)
The endocardial binary appearance ('binary sign') is an unreliable marker for echocardiographic detection of Fabry disease in patients with left ventricular hypertrophy. (2011) (33)
Clinical features of thrombophilia in families with gene defects in protein C or protein S combined with factor V Leiden. (1998) (33)
E-Selectin and restenosis after femoropopliteal angioplasty: prognostic impact of the Ser128Arg genotype and plasma levels (2003) (33)
No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene. (1999) (32)
CYP2C9*2 and CYP2C9*3 alleles confer a lower risk for myocardial infarction. (2004) (32)
Impact of variables of the P-selectin – P-selectin glycoprotein ligand-1 axis on leukocyte-platelet interactions in cardiovascular disease (2014) (32)
Clinical restenosis after coronary stent implantation is associated with the heme oxygenase-1 gene promoter polymorphism and the heme oxygenase-1 +99G/C variant. (2005) (32)
Identification of Mutations in the Canine von Willebrand Factor Gene Associated with Type III von Willebrand Disease (1998) (32)
Interleukin-6 and interleukin-6 promoter polymorphism (−174) G>C in patients with spontaneous venous thromboembolism (2006) (31)
Trypsin activation of human factor XI. (1980) (31)
Prothrombin Fragment F1+2 Is not Predictive for Recurrent Venous Thromboembolism (1997) (31)
Butyrylcholinesterase activity predicts long-term survival in patients with coronary artery disease. (2012) (31)
C1-Esterase Inhibitor in Uncomplicated Pregnancy and Mild and Moderate Preeclampsia (1991) (31)
Prognostic value of neutrophils in patients with asymptomatic carotid artery disease. (2013) (30)
Relapse of Philadelphia chromosome positive acute lymphoblastic leukaemia after marrow transplantation: sustained molecular remission after early and dose‐escalating infusion of donor leucocytes (1997) (30)
Protein C promoter polymorphisms associate with sepsis in children with systemic meningococcemia (2007) (30)
The effect of p22-PHOX (CYBA) polymorphisms on premature coronary artery disease (≤ 40 years of age) (2010) (30)
FVIII-binding IgG modulates FVIII half-life in patients with severe and moderate hemophilia A without inhibitors. (2016) (29)
Improved characteristics of aPC-resistance assay: Coatest aPC resistance by predilution of samples with factor V deficient plasma. (1996) (29)
DNA repair polymorphisms associated with cytogenetic subgroups in B‐cell chronic lymphocytic leukemia (2009) (28)
Glycoprotein Ib polymorphisms influence platelet plug formation under high shear rates (2003) (28)
Risk of recurrence after a first venous thromboembolic event in young women (2007) (28)
[Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction]. (1993) (28)
Polymorphisms Associated with Both Noncardioembolic Stroke and Coronary Heart Disease: Vienna Stroke Registry (2009) (28)
Polymorphisms in inflammatory genes and the risk of ischemic stroke and transient ischemic attack: results of a multilocus genotyping assay. (2009) (28)
The E-selectin S128R polymorphism is not a risk factor for coronary artery disease in patients with diabetes mellitus type 2. (2003) (27)
The C-reactive protein (+)1444C/T alteration modulates the inflammation and coagulation response in human endotoxemia. (2006) (27)
No impact of endogenous prothrombotic conditions on the risk of central venous line‐related thrombotic events in children: results of the KIDCAT study (KIDs with Catheter Associated Thrombosis) (2014) (27)
The role of fibrinogen plasma levels, the –455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis (2011) (27)
Polymorphism of the complement 5 gene and cardiovascular outcome in patients with atherosclerosis (2012) (27)
Mean platelet volume predicts outcome in patients with asymptomatic carotid artery disease (2014) (27)
The Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms influence the late inflammatory response in human endotoxemia. (2005) (26)
T‐ and B‐cell clonality and frequency of human herpes viruses‐6, ‐8 and Epstein Barr virus in angioimmunoblastic T‐cell lymphoma (2004) (26)
Phenotyping and Target Expression Profiling of CD34+/CD38− and CD34+/CD38+ Stem- and Progenitor cells in Acute Lymphoblastic Leukemia (2018) (26)
Unilateral chronic thromboembolic pulmonary disease associated with combined inherited thrombophilia. (2002) (25)
Evaluation of a new screening assay ProC Global for identification of defects in the protein C/protein S anticoagulant pathway. (1997) (25)
Identification of a defective factor XI cross-reacting material in a factor XI-deficient patient. (1987) (25)
Fractalkine receptor polymorphisms V249I and T280M as genetic risk factors for restenosis (2005) (25)
Chronic myeloid leukemia: Pathophysiology, diagnostic parameters, and current treatment concepts (2003) (25)
Fixation of Brain Tumor Biopsy Specimens with RCL2 Results in Well‐Preserved Histomorphology, Immunohistochemistry and Nucleic Acids (2010) (23)
Spectrum of causative mutations in patients with haemophilia A in Austria (2010) (23)
Influence of cytochrome 2C19 allelic variants on on-treatment platelet reactivity evaluated by five different platelet function tests. (2012) (23)
Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden. (2017) (23)
Unusual peripheral T cell lymphoma presenting as acute liver failure and reappearing in the liver allograft. (2000) (22)
Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients. (1996) (22)
Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants (2001) (22)
Plasma protein adsorption to hemodialysis membranes: studies in an in vitro model. (1993) (22)
The prothrombin G20210A mutation and factor V Leiden mutation in patients with cerebrovascular disease. (1998) (21)
Molecular genetic differentiation between primary lung cancers and lung metastases of other tumors. (1996) (21)
Vienna Stroke Registry. Impact of the platelet glycoprotein Ib alpha Kozak polymorphism on the risk of ischemic cerebrovascular events: a case–control study (2004) (21)
Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis (1998) (21)
Relationship of myc protein expression to the phenotype and to the growth potential of HOC-7 ovarian cancer cells. (1992) (21)
Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia (1999) (21)
Anti-cardiolipin antibodies and overall survival in a large cohort: preliminary report. (2006) (20)
Interleukin-6 G(−174)C polymorphism is associated with mental retardation in cystic periventricular leucomalacia in preterm infants (2009) (20)
Phospholipids accelerate factor IX activation by surface bound factor XIa (1984) (20)
The influence of thrombophilia on the long-term survival of patients with a history of venous thromboembolism (2012) (19)
Quantitative monitoring of BCR/ABL1 mutants for surveillance of subclone-evolution, -expansion, and -depletion in chronic myeloid leukaemia. (2012) (19)
Risk of recurrence after a first venous thromboembolic event in young women. (2007) (19)
The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism (2007) (19)
EVI1 and MDS1/EVI1 expression during primary human hematopoietic progenitor cell differentiation into various myeloid lineages. (2012) (19)
Resistance to activated protein C (APC): mutation at ARG506 of coagulation factor V and vascular access thrombosis in haemodialysis patients (1996) (19)
Women with homozygous AT deficiency type II heparin-binding site (HBS) are at high risk of pregnancy loss and pregnancy complications (2017) (18)
CRM+ severe Fletcher factor deficiency associated with Graves' disease. (1984) (18)
The Factor V (Leiden) test: evaluation of an assay based on dilute Russell Viper Venom Time for the detection of the Factor V Leiden mutation. (1999) (18)
Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolism. (2005) (18)
The Thr715Pro Polymorphism of the P-Selectin Gene Is Not Associated With Ischemic Stroke Risk (2007) (18)
Interleukin-1 cluster combined genotype and restenosis after balloon angioplasty (2003) (17)
Simultaneous analysis of MDR1 C3435T, G2677T/A, and C1236T genotypes by multiplexed mutagenically separated PCR (2005) (17)
Interleukin-6 promoter genotype and restenosis after femoropopliteal balloon angioplasty: initial observations. (2004) (17)
Prekallikrein, HMW-kininogen and factor XII in various disease states. (1983) (17)
The relation between erythrocyte volume and folate levels is influenced by a common mutation in the methylenetetrahydrofolate reductase (MTHFR) gene (C677T). (2000) (16)
Age-specific PCA3 score reference values for diagnosis of prostate cancer (2012) (16)
Two New Frequent Dimorphisms in the Protein S (PROS1) Gene* (1996) (16)
Serum-tryptase at diagnosis: a novel biomarker improving prognostication in Ph(+) CML. (2014) (16)
C-reactive protein 3' UTR +1444C>T polymorphism in patients with spontaneous venous thromboembolism. (2006) (16)
Factor VII gene haplotypes and risk of ischemic stroke. (2006) (16)
Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma (2001) (16)
Biocompatibility of artificial surfaces such as cellulose and related materials (1993) (16)
Evaluation of a highly specific functional test for the detection of factor V Leiden (2000) (15)
Monitoring neutrophils and platelets during casein‐induced anaphylaxis in an experimental BALB/c mouse model (2012) (15)
Vitamin K epoxide reductase (VKORC1) gene mutations in osteoporosis: A pilot study. (2010) (15)
Detection of engraftment and mixed chimerism following bone marrow transplantation using PCR amplification of a highly variable region-variable number of tandem repeats (VNTR) in the von Willebrand factor gene (1991) (15)
Alternative end-joining in follicular lymphomas’ t(14;18) translocation (2002) (15)
The fibrinogen -148 C/T polymorphism influences inflammatory response in experimental endotoxemia in vivo. (2007) (15)
Interleukin-1 gene cluster variants and abdominal aortic aneurysms (2005) (15)
Carcinogen-specific mutations in the p53 tumor suppressor gene in lung cancer. (1994) (15)
PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus (2005) (14)
Impact of αENaC Polymorphisms on the Risk of Ischemic Cerebrovascular Events: A Multicenter Case–Control Study (2005) (14)
Thrombotic tendency in 75 symptomatic, unrelated patients with APC resistance. (1996) (14)
Spectrum of germ-line MLH1 and MSH2 mutations in Austrian patients with hereditary nonpolyposis colorectal cancer (2005) (14)
Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause (2016) (14)
Prospective Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia with Inversion(16) by CBFβ/MYH11 RT-PCR: Implications for a Monitoring Schedule and for Treatment Decisions (2001) (14)
Multiplex PCR assay for the detection of genetic variants of α1-antitrypsin (1999) (14)
P‐selectin mRNA is maintained in platelet concentrates stored at 4°C (2009) (14)
FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H☆ (2013) (13)
Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusion (1996) (13)
Plasminogen Deficiency: An Additional Risk Factor for Thrombosis in a Family with Factor V R506Q Mutation? (1996) (13)
Increased expression of transient receptor potential canonical 6 (TRPC6) in differentiating human megakaryocytes (2016) (13)
Long term follow up after allogeneic stem cell transplantation for chronic myelogenous leukemia. (1998) (13)
Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage (2015) (12)
Emergence of an unusual bone marrow precursor B-cell population in fatal Shwachman-Diamond syndrome. (2000) (12)
High levels of platelet-monocyte aggregates after valve replacement for aortic stenosis: relation to soluble P-selectin and P-selectin glycoprotein ligand-1 genes. (2012) (11)
Properties and units in the clinical laboratory sciences. Part XVIII. Properties and units in clinical molecular biology (IUPAC Technical Report) (2004) (11)
TKI rotation-induced persistent deep molecular response in multi-resistant blast crisis of Ph+ CML (2017) (11)
Clinical and prognostic significance of histamine monitoring in patients with CML during treatment with imatinib (STI571). (2007) (11)
Molecular genetics and development of mast cells: implications for molecular medicine. (1997) (11)
A hitherto unknown splice site defect in the protein S gene (PROS1): the mutation results in allelic exclusion and causes type I and type III protein S deficiency (1997) (10)
The Thr715Pro variant impairs terminal glycosylation of P-selectin (2012) (10)
Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancy (2006) (10)
Comparison of methods for determination of interleukin 6 G(-174)C promoter polymorphism. (2002) (10)
Maternal interleukin-6 (−174) C/C polymorphism is associated with chorioamnionitis and cystic periventricular leucomalacia of the preterm infant (2010) (10)
Biochemical and functional properties of factor XI and prekallikrein. (1987) (10)
Possible clinical effects of the interaction of hemodialysis membranes with adhesion proteins. (1995) (10)
A frequent mutation in the protein S gene results in cryptic splicing (1997) (10)
UDP-glucuronosyltransferase 2B17 genotype and the risk of lung cancer among Austrian Caucasians. (2013) (10)
677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke (1998) (9)
Long-lasting complete response to imatinib in a patient with systemic mastocytosis exhibiting wild type KIT. (2014) (9)
Oncostatin M is a FIP1L1/PDGFRA‐dependent mediator of cytokine production in chronic eosinophilic leukemia (2013) (9)
Autoimmune Lymphoproliferative Syndrome (ALPS) Caused by Fas (CD95) Mutation Mimicking Sarcoidosis (2008) (9)
Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation (1999) (9)
Multiplex PCR assay for the detection of genetic variants of alpha1-antitrypsin. (1999) (9)
Impact of Escherichia coli K12 and O18:K1 on human platelets: Differential effects on platelet activation, RNAs and proteins (2018) (8)
Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation (2001) (8)
Effects of 3‐Azidothymidine on Platelet Counts, Indium‐111‐Labelled Platelet Kinetics, and Antiplatelet Antibodies (1989) (8)
The impact of uric acid on long-term mortality in patients with asymptomatic carotid atherosclerotic disease. (2015) (8)
Laboratory methods in the haemostatic laboratory (2006) (8)
Detection of trisomy 12 in chronic lymphocytic leukaemia: comparison of a polymerase chain reaction based technique with fluorescence in situ hybridization (1994) (8)
Influence of cytochrome P450 2C9*2 and 2C9*3 variants on the risk of ischemic stroke: a cross-sectional case-control study. (2005) (8)
Certification of reference materials for detection of the human prothrombin gene G20210A sequence variant (2008) (8)
Molekularbiologie und Hämostase (2008) (8)
Identification of an ancient haemophilia A splice site mutation. (2012) (8)
Polymorphisms in the coagulation factor VII gene and risk of primary intracerebral hemorrhage (2007) (8)
Rapid neonatal diagnosis of type IIB von Willebrand disease using the polymerase chain reaction. (1991) (7)
Detection of Trisomy 8 in Donor-Derived Ph− Cells in a Patient with Ph+ Chronic Myeloid Leukemia Successfully Treated with Imatinib (STI571) in Relapse after Allogeneic Transplantation (2004) (7)
Coagulation factor XII activity, activated factor XII, distribution of factor XII C46T gene polymorphism and coronary risk: reply to a rebuttal (2008) (7)
Low transplant-related mortality in patients receiving unrelated donor marrow grafts for leukemia (1999) (7)
Biomarkers for arterial and venous thrombotic disorders (2014) (7)
Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Polymorphism 663 C>T Affects Clotting Factor VIII Activity and Increases the Risk of Venous Thromboembolism. (2006) (7)
The inflammatory response is influenced by FXIII VAL 34 LEU polymorphism in a human LPS model (2009) (7)
Homozygous antithrombin deficiency type II causing neonatal thrombosis. (2017) (7)
Identification of a Neoplastic Stem Cell in Human Mast Cell Leukemia (2014) (7)
Identification of the target platelet glycoprotein in autoimmune thrombocytopenia occurring after allogeneic bone marrow transplantation (1989) (7)
Genetic variations and their influence on risk and treatment of venous thrombosis. (2008) (7)
Surface Adsorption of Factor XI: Association of Adsorption Sites with the Heavy Chain of Activated Factor XI (1980) (6)
Purification of plasma protein. (1988) (6)
Modulation of the immunophenotype of ovarian cancer cells by N,N‐dimethylformamide and transforming growth factor‐β1 (1993) (6)
Prognostic value of T-cell receptor γ rearrangement in peripheral blood or bone marrow of patients with peripheral T-cell lymphomas (2008) (6)
Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation (2005) (6)
Impact of alphaENaC polymorphisms on the risk of ischemic cerebrovascular events: a multicenter case-control study. (2005) (6)
The P-selectin gene Pro715 allele and low levels of soluble P-selectin are associated with reduced P2Y12 adenosine diphosphate receptor reactivity in clopidogrel-treated patients. (2011) (5)
Sunday, 26 August 2012 (2012) (5)
Combined occurrence of a heterozygous missense mutation in the protein C gene and allelic exclusion of one protein S allele leading to severe venous thrombosis. (2001) (5)
Influence of Imprinting of an X Chromosome and of the MethyleneTetrahydrofolate Reductase (MTHFR) 677C>T Polymorphism on FVIII Activity (2015) (5)
Founder effect in protein S-deficient families sharing a hot spot mutation in PROS1. (1999) (5)
High Levels of Soluble P-Selectin Are Associated with the Risk of Venous Thromboembolism and the P-Selectin Thr715 Variant. (2006) (5)
Surface Adsorption of Factor XI: II. Evidence that Different Mechanisms Are Involved in Binding to Glass and Plastic Materials (1982) (5)
Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia (1996) (5)
Molecular Disease Eradication is a Prerequisite for Long-term Remission in Patients with t(8;21) Positive Acute Myeloid Leukemia: a Single Center Study (2004) (5)
Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia (2000) (5)
Combined effects of genetic polymorphisms of P-selectin and P-selectin glycoprotein ligand-1 on the binding of platelets to monocytes. (2010) (5)
Predictive value of clone-specific CDR3 PCR in high-grade non-Hodgkin's lymphoma: long-term persistence of a clone-specific rearrangement in a patient with secondary high-grade NHL in remission after high-dose therapy. (1997) (5)
Simultaneous detection of co-segregating missense mutations of the Toll-like receptor 4. (2002) (5)
G-CSF stimulation of donor myelopoiesis prolongs survival of relapsed BCR-ABL-positive acute lymphoblastic leukemia after allogeneic marrow transplantation. (1996) (5)
Graft-versus-host disease following second syngeneic stem cell transplantation for relapsed chronic myeloid leukemia (1998) (5)
Plasminogen activator inhibitor-1 and outcome after femoropopliteal angioplasty: analysis of genotype and plasma levels (2003) (4)
The association of the Thr715Pro P‐selectin genotype with levels of P‐selectin in platelet concentrates (2014) (4)
The effect of synthetic polymer surfaces on the activation of factor XI in plasma: influence of heparin. (1984) (4)
Clotting activities and antigen concentrations of contact factors in kidney disease. (1985) (4)
Association between the rs342293 polymorphism and adverse cardiac events in patients undergoing percutaneous coronary intervention (2014) (4)
Identification of a variable number tandem repeat region in the human T cell receptor alpha-delta (TCRAD) locus (1996) (4)
Hypergranular acute lymphoblastic leukemia (ALL) (1993) (4)
[New developments in molecularbiological diagnostic]. (2017) (4)
Polymorphisms and Noncardioembolic Stroke in Three Case-Control Studies (2011) (4)
Analysis of Clonal Cell Growth Using X-Chromosome Inactivation Patterns (1998) (3)
Combined dys-form of homozygous factor XI deficiency and heterozygous factor XII deficiency. (1985) (3)
CYP2C9 genotype and association with bone mineral density: a pilot study. (2013) (3)
Association of periprocedural neurological deficit in carotid stenting with increased anticardiolipin antibodies. (2009) (3)
An unusual case of myelodysplastic syndrome with prolonged clonal stability, indolent clinical course over a decade, and spontaneous regression of AML in the terminal phase (2005) (3)
Adsorption of coagulation factors on to haemodialysis membranes during standard haemodialysis (1993) (3)
Faktor XII-Mangel und Thrombophilie (1993) (3)
Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9‐mediated dose requirements of vitamin K antagonist therapy: a pilot study (2014) (3)
A microsatellite polymorphism in the Heme Oxygenase - 1 gene promoter is associated with increased serum bilirubin and HDl levels but not with a decreased risk for coronary artery disease (2003) (3)
Continuous complete clinical and molecular remission in two patients with refractory lymphoid malignancies after autografting followed by allogeneic stem cell transplantation with reduced intensity conditioning (2002) (2)
Platelet glycoprotein Ibα polymorphisms and function evaluated by the platelet function analyzer PFA-100 in patients with lupus anticoagulant: the association with thromboembolic disease (2007) (2)
Genetische Veränderungen des Protein-C-Systems (1998) (2)
Contact Activation of Factor XI (1981) (2)
The Malmö International Brother Study (MIBS). Genetic defects and inhibitor development in siblings with severe hemophilia A. (2005) (2)
Infections and the role of plasma proteins and platelets (2014) (2)
A multilocular B-cell neoplasia presenting as multiple myeloma and polymorphic lymphoma of recipient origin 2 months after kidney transplantation in a heart-transplant recipient (1996) (2)
Faktor XII: Biochemie, Molekularbiologie, Physiologie (1999) (2)
The Toll-Like Receptor 4 Asp299Gly and Thr399Ile Polymorphisms Influence the Late Inflammatory Re- sponse in Human Endotoxemia, (2005) (2)
Kinetics of minimal residual disease during induction/consolidation therapy in standard-risk adult B-lineage acute lymphoblastic leukemia (1995) (2)
Inhibitor development in two patients with mild haemophilia A – spontaneous disappearance and no recurrence of the inhibitor after re-challenge (2012) (2)
[Practice guidelines for formulation of patient or subject information and for the declaration of consent in genetic studies (inclusive of pharmaceutical genetics]. (2001) (2)
Are inherited thrombotic risk factors associated with fibrostenosis in Crohn's disease? (2011) (2)
Variant intra philadelphia translocation with rearrangement of BCR-ABL and ABL-BCR within the same chromosome in a patient with cALL. (2000) (2)
Polymorphism of the palladin gene and cardiovascular outcome in patients with atherosclerosis (2011) (2)
A multilocular B-cell neoplasia presenting as multiple myeloma and polymorphic lymphoma of recipient origin 2 months after kidney transplantation in a heart-transplant recipient. (1996) (2)
MINI-REVIEW AND REPORT OF THREE CASES Post-transplant acute myeloid leukemia (PT-AML) (1999) (1)
The EGF A61G polymorphism is associated with shorter disease-free period and survival in malignant melanoma (2006) (1)
Studies on the prothrombin--complex. (1979) (1)
Ökonomische Perspektiven der Stammzellforschung (2008) (1)
VKORC1 Polymorphisms And Chronic Thromboembolic Pulmonary Hypertension (2010) (1)
Evaluation of the PC-1 K121Q and G2906C variants as independent risk factors for ischaemic stroke (2011) (1)
Vergleichende Untersuchung eines hereditären, unbehandelten Faktor-VIII-Mangelplasmas mit einem hereditären, dampfbehandelten Produkt (1987) (1)
Anwendung von P53-Gen-Analysen in der thoraxchirurgischen Onkologie am Beispiel des solitären pulmonalen Rundherdes (1996) (1)
The effect of p 22-PHOX ( CYBA ) polymorphisms on premature coronary artery disease ( ≤ 40 years of age ) (2018) (1)
Opposite effects of CX3CR1 receptor polymorphismsV249I andT280Mon the development of acute coronary syndrome A possible implication of fractalkine in inflammatory activation (2017) (1)
Screening by Genomic Linkage Studies and Mutation Analysis of Hereditary Adenomatous Polyposis Coli: Usefulness for Clinical Practice (1996) (1)
KIT D816V Mutation Burden Predicts Prognosis and Survival In Patients With Mastocytosis and Correlates With The WHO Type Of The Disease (2013) (1)
Der Professorinnenclub der Medizinischen Universität Wien (2009) (1)
Phenotyping Of Leukemic Stem Cells In Ph+ ALL and Ph- ALL Reveals Unique Profiles Of Markers and Targets In Distinct Disease Variants (2013) (1)
Characterization and Diagnostic Work-up of a Patient with Functionally Impaired Platelet GP6 (2017) (1)
The Oncogenic Transcription Factor STAT5 Triggers Aberrant Expression Of CD25 (IL-2RA) In Neoplastic Stem Cells In Ph+ CML (2013) (1)
The VKORC1 polymorphism rs9923231 is associated with aneurysms of the ascending aorta in an Austrian population. (2017) (1)
K-ras mutations as pathogenetic and diagnostic markers in pancreatic cancer (1998) (1)
Factor V Leiden Mutation Increases the Risk of Venous Thromboembolism in Cancer Patients – Results From the Vienna Cancer and Thrombosis Study (CATS). (2012) (1)
Molecular Remission after Induction Chemo- Immunotherapy and Rituximab Maintenance in Previously Untreated Follicular Lymphoma. (2009) (1)
Diagnose der Vererbung des Typ IIb von Willebrand-Defekts mit Hilfe der Polymerase-Kettenreaktion (1991) (0)
Allgemeine Grundlagen der Hemmkörperbildung (1989) (0)
Molekularbiologie in der medizinischen Diagnostik (1994) (0)
Nachruf: Professor Dr. rer. nat. Norbert Heimburger (2007) (0)
Faktor VIII als Ursache für Hämophilie und Thrombophilie? (2003) (0)
Der Professorinnenclub der Medizinischen Universität Wien : Eine Initiative zur Förderung von Frauen und Frauennetzwerken in den medizinischen Wissenschaften (Originalartikel) (2009) (0)
Molekularbiologische Grundlagen und Diagnostik der Hämophilie A (1994) (0)
Wechsel in der Schriftleitung (2009) (0)
Hämostaseologie – das neue Verbandsorgan der GTH (2004) (0)
Blutgerinnungsstörungen im Tiermodell: Charakterisierung des Typ-3-von-Willebrand-Faktor-Mangels beim Hund (1998) (0)
Qualitätssicherung im hämostaseologischen Labor (2010) (0)
Aktuelle praktische Bedeutung gentechnologischer Entwicklungen (1989) (0)
Molekulargenetische Untersuchungen beim yon Willebrand-Syndrom (1990) (0)
P53 — vom prognostischen zum prädiktiven Marker (2000) (0)
Molekularbiologische Diagnostik in der Hämostaseologie (1998) (0)
Molekularbiologie des Protein-C- und Protein-S-Mangels (1996) (0)
Hochmolekulares Kininogen : Biochemie und Funktion (1987) (0)
Genetik verstehen (2011) (0)
Impact-Faktor 2010 = 0,780 (2011) (0)
Österreichische Erfahrungen bei der Verwendung von RFLP-Analysen zur Konduktorinnen-Diagnose bei Hämophilie A (1988) (0)
Resistenz gegen aktiviertes Protein C, Faktor-V-Leiden und Prothrombin-G-20210-A-Variante bei Kindern mit ischämischen Schlaganfällen (2000) (0)
Genetische Prädisposition für das Mammakarzinom : Übersicht die molekulargenetischen Grundlagen einer lange bekannten epidemiologischen Beobachtung (1995) (0)
Gebietsbezeichnung Hämostaseologie in der Weiterbildungsordnung verankert (2003) (0)
Combined haplotypes of protein C and endothelial protein C receptor (2009) (0)
Protein C Promoter Genotypes Associate with Susceptibility, Development of Sepsis, and Lower Blood Pressure in Young Children with Systemic Meningococcemia (2008) (0)
A matched case control study (2017) (0)
P-052: Mild-to-moderate bleeding tendency of unknown cause is common in women and might be caused by increased fibrinolysis (2017) (0)
Abstract TMP50: A Polymorphism in HDAC9 was Associated with Large Vessel Stroke in the Vienna and German Stroke Studies (2013) (0)
The importance of quality assurance in molecular genetic laboratories (2010) (0)
multiple myeloma and polymorphic lymphoma of recipient origin 2 months after kidney transplantation in a heart-transplant recipient (2005) (0)
Abstract 13129: A 4q25 Variant and Cardioembolic Stroke in the Vienna Stroke Registry (2010) (0)
A GENETIC RISK SCORE FOR ATRIAL FIBRILLATION IS ASSOCIATED WITH CARDIOEMBOLIC STROKE (2013) (0)
A New Prognostic Score for Aggressive B-Cell Lymphoma with C-MYC Translocation Integrating Clinical and Genetic Features. (2012) (0)
Abstract 13827: The Influence of Cytochrome 2c19 Allelic Variants on Clopidogrel-Mediated Platelet Inhibition Evaluated by Five Different Platelet Function Tests (2010) (0)
Comparison of BCR-ABL1 quantification in peripheral blood and bone marrow using an International Scale-standardized assay for assessment of deep molecular response in chronic myeloid leukemia (2020) (0)
Proliferation Kinetics of Subclones Carrying Point Mutations In the BCR-ABL TKD During TKI Treatment In CML Patients: Quantitative Monitoring by LD-PCR (2010) (0)
mutationof homozygotes for the 845G>A (C282Y) hereditary hemochromatosis promoter polymorphisms and liver abnormalities a Tumor necrosis factor (2002) (0)
Clinical Features of VTE and Risk Factors for Thrombosis in the Patient Group (2001) (0)
Faktor XI: Physiologie, Biochemie, Molekularbiologie (1999) (0)
[Molecular genetic studies in the von Willebrand's syndrome]. (1990) (0)
PBPC mobilization with chemotherapy and G–CSF in patients with chronic myeloid leukemia: quantification of bcr/abl‐positive cells by interphase fluorescence in situ hybridization and competitive PCR (2001) (0)
Histamine Monitoring in Patients with CML during Treatment with Imatinib: Comparison to Monitoring by Cytogenetics and BCR/ABL. (2005) (0)
women with a history of venous thromboembolism Temporary increase in the risk of recurrence during pregnancy in (2013) (0)
Philadelphia chromosome and bcr abl rearrangement following bone marrow transplantation of ph positive cml (1990) (0)
Regular Article Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm (2002) (0)
The Influence of the-1639 G > A Variant on the Expression of the Vitamin K Epoxide Reductase Gene in hFOB 1 Cells (2009) (0)
Predictive Value of Clonal Peripheral Blood γTCR Rearrangement in Patients with Peripheral T-Cell Lymphoma. (2006) (0)
Diagnosis of carriers of haemophilia A by RFLP analysis: Austrian results. (1990) (0)
P-1 Two Stents Implantation Technology of Endovascular Repair in Treatment of Type B Aortic Dissection (2015) (0)
Multiplex PCR Assay for the Detection of Genetic Variants of a 1 (1999) (0)
BCR-ABL IS-MMR EHA Meeting 2011 (2011) (0)
Acknowledgement to referees (2006) (0)
Ex Vivo Improvement of a von Willebrand Disease Type 2A Phenotype Using an Allele-Specific Small Interfering RNA (2020) (0)
Drought and malaria retreat in the Sahel , West Africa (2002) (0)
Next Generation Sequencing Identifies DNA Methylation Patterns Indicative of Disease Progression in Ph+ CML (2014) (0)
Identification and characterization of a defect of a homozygous factor XI deficient patient with cross-reacting material (1986) (0)
Deep Venous Thrombosis of the Lower Extremity in a 16-Year-Old Girl with Homozygous MTHFR- and Heterozygous Factor V Leiden-Mutation (2004) (0)
CARDIOLOGY 2002; September 26-28, 2002; Hofburg, Vienna, Austria; Jointly organized by: Division of Cardiovascular Diseases, Mayo Clinic; Division of Cardiology, University of Vienna (2018) (0)
Comment on: Genetic variation of the platelet surface integrin GPIIb-IIIa (PIA1/A2-SNP) shows a high association with Type 2 diabetes mellitus by Goodall AH et al. (2004) (0)
ENOMICS nfluence of functional haplotypes in the rug transporter gene ABCB 1 on central ervous system drug distribution in humans (2005) (0)
Improvement of inter-laboratory standardisation for BCR-ABL quantification with secondary reference material calibrated on WHO Reference Panel (2011) (0)
Poster session I * Thursday 9 December 2010, 08:30-12:30 (2010) (0)
Gene Polymorphisms and Signaling Defects (2013) (0)
Pharmacogenetics guided anticoagulation (2010) (0)
[The Club of Female Professors of the Medical University Vienna]. (2009) (0)
[Molecular biology of tobacco smoke associated neoplasia]. (1996) (0)
Impact-Faktor 2011 = 1,190 (2012) (0)
[Transgenic foods--advantages and risks]. (1997) (0)
Relationship ofmyc protein expression tothephenotype andtothe growth potential ofHOC-7ovarian cancercells (1992) (0)
Genetics of Vascular Diseases (2019) (0)
Abstract (1984) (0)
Abstract (1984) (0)
ORAL ANTICOAGULANTS AND FETAL LOSS. AUTHORS' REPLY (1996) (0)
A 75-year-old man with fever, diarrhea, weight loss and a mid-esophageal mass. (2002) (0)
Interaction Of Factor XI With Activating And Non-Activating Surfaces (1981) (0)
Commercial Immunodepleted Deficient Plasmas Contain Cleaved High Molecular Weight Kininogen (HK) (1988) (0)
List of Authors and Speakers (1988) (0)
[Genetic predisposition for breast carcinoma: overview of molecular genetic principles from long familial epidemiologic observation]. (1995) (0)
Impact of Escherichia coli K12 and O18:K1 on human platelets: Differential effects on platelet activation, RNAs and proteins (2018) (0)
IMMUN0BL0TTING STUDIES OF THE INTERACTION OF PLASMA-FACT0R XI WITH KAOLIN (1987) (0)
Abstract 1963: Elevated Anticardiolipin Antibodies are an Independent Risk Factor for Neurological Complications in Carotid Stenting (2006) (0)
Abstracts of the 37th annual meeting of the GTH (Gesellschaft für Thrombose- und Hämostase-forschung) (2005) (0)
University of Wien Wien , Austria Single-Step Isolation of N-Linked Glycans from Deglycosylation Reaction Mixtures (0)
Tirofiban potentiates agonist-induced platelet activation and degranulation, despite effectively inhibiting aggregation (2022) (0)
-to: Tschoepe D, Menart B, Ferber P et al. (2003) genetic variation of the platelet surface integrin GPIIb-IIIa (PIA1/A2-SNP) shows a high association with Type 2 diabetes mellitus. Diabetologia 46:984-989. (2003) (0)
ID: 136 No Evidence for an Association of the Tissue-type Plasminogen Activator -7351C/T Enhancer Polymorphism and the Presence of Stable Coronary Artery Disease or the Occurrence of Acute Myocardial Infarction (2006) (0)
Imatinib Inhibits SCF-Induced Development Of Human Mast Cells In Vitro and Induces Profound and Selective Mast Cell Deficiency In Patients With Ph+ CML (2013) (0)
Oral anticoagulants and fetal loss (1996) (0)
Abstracts of the 8th European Symposium on Platelet and Granulocyte Immunobiology, Seehotel Rust, Rust, Austria, May 13–16, 2004 (2004) (0)
Title Page / Table of Contents, Vol. 18, Supplement 1, 1988 (1988) (0)
PP43 RCL2 fixation of neurosurgical specimens: well preserved histomorphology and DNA integrity (2009) (0)
Association between IL-6–174 (G/C) polymorphism and cystic periventricular leukomalacia in preterm infants (2006) (0)
Acs:180 Results Obtained for Macroprolactinemic Samples Multiplexed Mutagenically Separated Pcr: Simulta- Neous Single-tube Detection of the Factor V R506q (g1691a), the Prothrombin G20210a, and the Methyl- Enetetrahydrofolate Reductase A223v (c677t) Variants (2001) (0)
Frühjahrstagung 2007 der Österreichischen Gesellschaft für Hämatologie und Onkologie (2007) (0)
IL-6–174 (G/C) Polymorphismus bei Frühgeborenen mit zystischer periventrikulärer Leukencephalomalazie (2007) (0)
Akute myeloische Leukämien (2003) (0)
Zusammenhang zwischen mütterlichem IL-6–174 (G/C) Polymorphismus, Chorioamnionitis, und zystischer periventrikulärer Leukencephalomalazie des Frühgeborenen (2007) (0)
Genetik und kolorektales Karzinom (1992) (0)
Neue Entwicklungen in der molekularbiologischen Diagnostik (2017) (0)

This paper list is powered by the following services:

Other Resources About Christine Mannhalter

en.wikipedia.org

What Schools Are Affiliated With Christine Mannhalter?

Christine Mannhalter is affiliated with the following schools:

Image Attributions

Image Source for Christine Mannhalter